ABSTRACT
Introduction Reliable estimates on maternal and child morbidity and mortality are essential for health programs and policies. Data are needed in populations which have the highest burden of disease but also have the least evidence and research, to design and evaluate health interventions to prevent illnesses and deaths that occur worldwide each year.
Methods and analysis The Birhan Maternal and Child Health (MCH) cohort is an open prospective pregnancy and birth cohort nested within the Birhan health and demographic surveillance system (HDSS). An estimated 2500 pregnant women are enrolled each year and followed through pregnancy, birth, and the postpartum period. Newborns are followed through two years of life to assess growth and development. Baseline medical data, signs and symptoms, laboratory test results, anthropometrics, and pregnancy and birth outcomes (stillbirth, preterm birth, low birthweight) are collected from both home and health facility visits. We will calculate the period prevalence and incidence of primary morbidity and mortality outcomes.
Ethics and Dissemination The cohort has received ethical approval. Findings will be disseminated at scientific conferences, peer-reviewed journals, and to relevant stakeholders including the ministry of health.
Strengths and limitations of this study
This cohort collects longitudinal data at multiple time points from pregnancy through birth and childhood in a setting where there are limited data.
Data from this study provide estimates for birth outcomes such as stillbirths, preterm birth, and low birth weight.
Results will inform risk profiles for maternal, neonatal, and child morbidity and mortality.
Similar to all observational studies, there are potential confounders that are unmeasurable.
Evidence from this study will support policies and programs to improve maternal and child health.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work has been supported by the Bill & Melinda Gates Foundation (Grant number INV-010382 and OPP1201842).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study has received the following ethical approvals: St. Paul's Hospital Millennium Medical College (PM23/274), Boston Children's Hospital (P00028224) and Harvard School of Public Health (19-0991). Results will be made available to the ministry of health, regional, zonal and district health offices. Publications will follow the HaSET publications guidelines. Birhan serves as the field site for HaSET ('happiness' in Amharic)-a maternal and child health research program in Ethiopia. For further details, please visit www.hasetmch.org.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data use is governed by the Birhan Data Access Committee (DAC) and follows Birhan's data sharing policy. All researchers who wish to access Birhan data can complete a Birhan data request form and submit it for decision by the Birhan DAC. Datasets will only be provided with de-identified data to maintain confidentiality of study participants.